Eva Guinan, MD, Pediatric Hematology & Oncology, Boston, MA, Boston Children's Hospital


Pediatric Hematology & Oncology Boston, MA

Professor of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School

Dr. Guinan is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Guinan's full profile

Already have an account?

  • Office

    450 Brookline Avenue
    Dana-Farber Cancer Institute
    Boston, MA 02215
    Phone(617) 632-4932
    Fax(617) 632-3770
  • Is this information wrong?

Education & Training

  • Boston Children's Hospital
    Boston Children's HospitalFellowship, Pediatric Hematology/Oncology, 1984 - 1986
  • Dana-Farber Cancer InstituteResidency, Pediatrics, 1982 - 1984
  • Boston Children's Hospital
    Boston Children's HospitalResidency, Pediatrics, 1980 - 1982
  • Harvard Medical School
    Harvard Medical SchoolClass of 1980

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1984 - 2021
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • America's Top Doctors for Cancer Castle Connolly, 2011-2019
  • Boston Magazine Castle Connolly, 2010-2019
  • America's Top Doctors Castle Connolly, 2009-2019

Clinical Trials

Publications & Presentations


Journal Articles

  • The Open Translational Science in Schizophrenia (OPTICS) Project: An Open-Science Project Bringing Together Janssen Clinical Trial and NIMH Data  
    Eva C Guinan, Joseph S Ross, Adam J Savitz, Nature

Press Mentions

  • Can AI Tools Segment A Cancer Tumor as Well as an Oncologist?
    Can AI Tools Segment A Cancer Tumor as Well as an Oncologist?May 21st, 2019
  • Harvard, Dana-Farber AI Challenge Uses Crowdsourcing to Improve Cancer Care
    Harvard, Dana-Farber AI Challenge Uses Crowdsourcing to Improve Cancer CareApril 18th, 2019
  • Scientists Are Training the Body to Accept New Organs
    Scientists Are Training the Body to Accept New OrgansJanuary 22nd, 2019
  • Join now to see all

Grant Support

  • rBPI21: Development of a novel radiation mitigatorDARPA2012–Present
  • In Vivo Irradiations With Patients Undergoing Radiation Therapy: DANA Farber CancNational Institute Of Allergy And Infectious Diseases2010–2011
  • Potential Role of rBPI21 in Ameliorating Radiation Toxicity: A Murine ModelDARPA2008–2011
  • Ex Vivo Alloanergization To Improve Immunity After Haploidentical TransplantNational Cancer Institute2009–2010
  • Rbpi21 &Endotoxin-Directed Innate Immunity In Stem Cell TransplantationNational Heart, Lung, And Blood Institute2008–2009
  • Endotoxin-directed Innate Immunity in Patients Undergoing Hematopoietic Stem Cell TransplantationDana Foundation2007–2009
  • Clinical CoreNational Cancer Institute2008
  • Cellular Correction Of Congenital Hematopoietic DisordersNational Heart, Lung, And Blood Institute2000–2002
  • Centers For Clinical Research On TransplantationDivision Of Blood Diseases And Resources1998–2000
  • Phase I/II Study Of Pixy 321 For Patients With Marrow Failure SyndromesNational Center For Research Resources1996–1997
  • Phase I/II Trial Of Pixy-321 For Patients With Amegakarypcytic ThrombocytopeniaNational Center For Research Resources1996
  • Phase I Study Of Recombinant Human Interleukin 11National Center For Research Resources1996

Professional Memberships

  • Member
  • American Society of Pediatric Hematology Oncology
  • American Society for Blood and Marrow Transplantation
  • International Pediatric Transplant Association

Other Languages

  • Swedish

Hospital Affiliations